Screener
Cytek Biosciences, Inc. CTKB APAC — Total
Other geography segments
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Cytek Biosciences, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NoncurrentAssets.
The source filing: Cytek Biosciences, Inc.’s 10-Q, filed August 5, 2026.
- Filed
- Aug 5, 2026, 5:06 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-053496
FAQ
- What is Cytek Biosciences, Inc.'s APAC — total?
- Cytek Biosciences, Inc. (CTKB) reported APAC — total of $9.58M in Q2 2026.
- How has Cytek Biosciences, Inc.'s APAC — total changed year-over-year?
- Cytek Biosciences, Inc.'s APAC — total increased by 0.7% year-over-year, from $9.52M to $9.58M.
- What is the long-term trend for Cytek Biosciences, Inc.'s APAC — total?
- Over 3 years (2022 to 2025), Cytek Biosciences, Inc.'s APAC — total has grown at a 43.7% compound annual growth rate (CAGR), from $12.83M to $38.02M.
- What does APAC — total mean?
- This metric captures the aggregate financial contribution from the Asia-Pacific segment, encompassing all revenue streams attributed to operations within this geographic area. It is used to evaluate the regional performance and strategic importance of the APAC market relative to the company's overall global business operations.
Ask your AI about Cytek Biosciences, Inc.'s apac — total.
Connect your AI assistant and compare segments, right in your chat.
Connect your AI
Claude